1. Home
  2. CNDT vs RIGL Comparison

CNDT vs RIGL Comparison

Compare CNDT & RIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNDT
  • RIGL
  • Stock Information
  • Founded
  • CNDT 2016
  • RIGL 1996
  • Country
  • CNDT United States
  • RIGL United States
  • Employees
  • CNDT N/A
  • RIGL N/A
  • Industry
  • CNDT Business Services
  • RIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CNDT Consumer Discretionary
  • RIGL Health Care
  • Exchange
  • CNDT Nasdaq
  • RIGL Nasdaq
  • Market Cap
  • CNDT 393.4M
  • RIGL 335.5M
  • IPO Year
  • CNDT N/A
  • RIGL 2000
  • Fundamental
  • Price
  • CNDT $2.78
  • RIGL $38.85
  • Analyst Decision
  • CNDT
  • RIGL Buy
  • Analyst Count
  • CNDT 0
  • RIGL 5
  • Target Price
  • CNDT N/A
  • RIGL $38.20
  • AVG Volume (30 Days)
  • CNDT 1.1M
  • RIGL 995.6K
  • Earning Date
  • CNDT 08-06-2025
  • RIGL 08-05-2025
  • Dividend Yield
  • CNDT N/A
  • RIGL N/A
  • EPS Growth
  • CNDT N/A
  • RIGL N/A
  • EPS
  • CNDT 0.06
  • RIGL 5.43
  • Revenue
  • CNDT $3,112,000,000.00
  • RIGL $267,921,000.00
  • Revenue This Year
  • CNDT N/A
  • RIGL $59.93
  • Revenue Next Year
  • CNDT $3.08
  • RIGL N/A
  • P/E Ratio
  • CNDT $45.22
  • RIGL $7.15
  • Revenue Growth
  • CNDT N/A
  • RIGL 105.62
  • 52 Week Low
  • CNDT $1.90
  • RIGL $12.66
  • 52 Week High
  • CNDT $4.90
  • RIGL $43.72
  • Technical
  • Relative Strength Index (RSI)
  • CNDT 57.62
  • RIGL 68.57
  • Support Level
  • CNDT $2.74
  • RIGL $39.00
  • Resistance Level
  • CNDT $2.94
  • RIGL $42.08
  • Average True Range (ATR)
  • CNDT 0.12
  • RIGL 2.32
  • MACD
  • CNDT 0.03
  • RIGL -0.37
  • Stochastic Oscillator
  • CNDT 69.52
  • RIGL 53.26

About CNDT Conduent Incorporated

Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

Share on Social Networks: